Committee debates parental-consent language for minors in HB543; substitute motion to table passes 5-4

House Bill 543, a proposal to clarify consent requirements so that minors under 18 generally must have parental involvement for reproductive and gender-affirming health care, drew extended testimony and a close committee vote Wednesday before the House Health & Human Services Committee.

Supporters argued the measure restores parental rights and ensures family involvement for life-altering medical choices; opponents said it would create unsafe situations for young people who cannot safely involve parents. After public and expert testimony, a substitute motion to table the bill passed 5-4, effectively removing it from the committee’s immediate calendar.

The bill text defines “minor” as “an individual who is under 18 years of age” and inserts a new section stating in part that nothing in the referenced health-care freedom act “shall be construed to allow a minor to receive gender affirming health care or reproductive health care without parental consent in any manner that is not otherwise provided for in law.” The sponsor said the change would allow parents to be involved and cited cases in other states where birth-certificate presumptions of parentage have been contested; the sponsor also described an expedited adoption process as one route to secure parentage documentation across state lines.

Witnesses in support included Jody Hendricks, executive director of New Mexico Family Action Movement, who told the committee, “Every child deserves the loving guidance of their parents, especially when facing major life decisions.” Another supporter, Michael Peterson of Freedom Families United, said the bill “ensures that parents are involved in these critical choices.”

Opponents included a law student testifying for Planned Parenthood of the Rocky Mountains, who said the bill would “force minors into unsafe situations” and stressed that some young people cannot safely involve parents. Dr. Molly McClain, a practicing physician in Albuquerque who provides gender care, urged a no vote and said she has not begun or changed gender-affirming medications without “deep engagement from parents,” adding that legislating clinical standards into law could harm patient care and clinician recruitment.

Committee members pressed witnesses on clinical risks and patient protections. A sponsor and other proponents argued that puberty blockers and cross-sex hormones carry risks including bone-density effects, fertility concerns and cardiovascular issues; medical witnesses differed on the frequency and reversibility of those outcomes in adolescent care.

After debate, Representative Anaya offered a substitute motion to table the bill; the motion was seconded. The roll call recorded five members voting to table and four voting against tabling, so the bill was taken off the agenda for further work in the interim.

The committee transcript records multiple references to existing law and earlier legislative actions: witnesses and sponsors referenced a prior measure (noted in testimony as HP 7) and the U.S. Supreme Court’s Dobbs decision. Committee members also discussed existing legal remedies — including court petitions and child-protection processes — that they said remain available where guardianship or abuse issues arise.

With the bill tabled, sponsors and opponents indicated the topic may be revisited in future interim work and that stakeholders would continue to press technical and policy concerns.